Mauro Picardo
Biographic Data
| ID | 5534402 |
|---|---|
| NAME | Mauro Picardo |
| GIVEN NAMES | Mauro |
| FAMILY NAME | Picardo |
| SIGNATURE | PICARDO M |
| AFFILIATIONS | San Gallicano Hospital |
| ORCID | 0000-0003-4899-6639 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2013 |
| H-INDEX | 0 |
Rome consensus conference - statement; human papilloma virus diseases in males
The Jury made Recommendations based on the scientific evidence presented by the Scientific Committee. Accordingly, for prevention purposes and social fairness and equality, as both sexes are affected by the disease, the vaccination of 12-year-old males against HPV should be recommended in order to guaranty protection to everyone. Aspects related to healthcare policy and economic sustainability, are to be discussed by respective public system repr…
Transparency or Proper Study Valuation Procedures Missed
To the Editor: We wish to thank the Editor for giving us the opportunity to think about and resolve a few potential issues with our paper. Garattini and colleagues have questioned the meaningfulness of the evidence used to inform some of the crucial parameter used in our model. This is because of a misalignment in the reference list, as a result of which, Table 1 in the paper points to the wrong references. We have fixed this and present the corr…
Novel Health Economic Evaluation of a Vaccination Strategy to Prevent HPV-related Diseases
BACKGROUND: The development of human papillomavirus (HPV)-related diseases is not understood perfectly and uncertainties associated with commonly utilized probabilistic models must be considered. The study assessed the cost-effectiveness of a quadrivalent-based multicohort HPV vaccination strategy within a Bayesian framework. METHODS: A full Bayesian multicohort Markov model was used, in which all unknown quantities were associated with suitable …
No prominent works on this page.
Novel Health Economic Evaluation of a Vaccination Strategy to Prevent HPV-related Diseases
BACKGROUND: The development of human papillomavirus (HPV)-related diseases is not understood perfectly and uncertainties associated with commonly utilized probabilistic models must be considered. The study assessed the cost-effectiveness of a quadrivalent-based multicohort HPV vaccination strategy within a Bayesian framework. METHODS: A full Bayesian multicohort Markov model was used, in which all unknown quantities were associated with suitable …
Rome consensus conference - statement; human papilloma virus diseases in males
The Jury made Recommendations based on the scientific evidence presented by the Scientific Committee. Accordingly, for prevention purposes and social fairness and equality, as both sexes are affected by the disease, the vaccination of 12-year-old males against HPV should be recommended in order to guaranty protection to everyone. Aspects related to healthcare policy and economic sustainability, are to be discussed by respective public system repr…
Transparency or Proper Study Valuation Procedures Missed
To the Editor: We wish to thank the Editor for giving us the opportunity to think about and resolve a few potential issues with our paper. Garattini and colleagues have questioned the meaningfulness of the evidence used to inform some of the crucial parameter used in our model. This is because of a misalignment in the reference list, as a result of which, Table 1 in the paper points to the wrong references. We have fixed this and present the corr…
Medicine (3 works) · Cervical Cancer and HPV Research (2 works) · Internal Medicine (2 works) · Vaccine Coverage and Hesitancy (2 works) · Accounting (1 work) · Accounting (1 work) · Actuarial science (1 work) · Bayesian probability (1 work) · Biostatistics (1 work) · Business (1 work)